Pasanting, Marjon T.

HRN: 22-58-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/13/2023
02/19/2023
IV
235mg
Q6
PCAP C
Waiting Final Action 
02/16/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/16/2023
02/23/2023
IV
720 Mg
Q6
PCAP C

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: